Upgrade to SI Premium - Free Trial

Piper Sandler on Medtronic, Inc. (MDT): 'Positive Read-Through for MDT'

October 14, 2026 8:28 AM
Piper Sandler analyst Matt O\'Brien reiterated a Neutral rating and $85.00 price target on Medtronic, Inc. (NYSE: MDT).The analyst commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments